Baxter International Shows Stability on Bottom Line - Analyst Blog

By
A A A

On July 8, we have updated our research report on Baxter International Inc. ( BAX ). The company depicts a stable earnings stream with positive surprises in three of the last four quarters with an average beat of 3.9%.

BAX, in fact, operates in the life-sustaining and critical care products category that should remain relatively insulated from economic downturns. Its products are not commodity-like in nature and provide a recurring revenue stream.

The Gambro acquisition strengthened BAX's role in the hemodialysis market. The acquisition helps the company gain an established set of products, which strengthen its existing line of dialysis products.

BAX released a promising guidance, both for the second quarter and full year 2014. For the second quarter of 2014, the company expects revenues to grow between 12 and 13%, barring the impact of foreign currency.

For full year 2014, BAX anticipates revenue growth in the range of 9 to 10%, excluding the impact of foreign exchange. The company also expects adjusted earnings between $5.05 and $5.25 per share for the year, reflecting year-over-year growth of 7.4 to 11.7%.

However, BAX depends on the EU market for about a third of its revenues. This is a cause for concern given recent fiscal tightening, a gloomy outlook for hospital spending and tightening of reimbursement.

Further, BAX faces pricing pressure due to the advent of group purchasing organizations (GPOs) in the U.S. The current economic climate has bolstered the bargaining power of GPOs, which might put pressure on the company's top line.

Currently, BAX retains a Zacks Rank #3 (Hold). Some better-ranked stocks in the medical products industry are OraSure Technologies, Inc. ( OSUR ), Wright Medical Group Inc. ( WMGI ), and Symmetry Medical, Inc. ( SMA ).

OraSure Technologies and Wright Medical Group retain a Zacks Rank #1 (Strong Buy), while Symmetry Medical carries a Zacks Rank #2 (Buy).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

WRIGHT MEDICAL (WMGI): Free Stock Analysis Report

BAXTER INTL (BAX): Free Stock Analysis Report

SYMMETRY MEDICL (SMA): Free Stock Analysis Report

ORASURE TECH (OSUR): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: WMGI , BAX , SMA , OSUR

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Can You Trust CarFax?
Can You Trust CarFax?               

Stocks

Referenced

Most Active by Volume

164,810,018
  • $16.16 ▲ 4.12%
50,233,746
  • $55.89 ▲ 4.66%
38,892,062
  • $37 ▲ 5.35%
36,824,964
  • $35.15 ▲ 1.88%
34,222,883
  • $9.74 ▲ 6.22%
32,620,827
  • $100.58 ▲ 0.01%
29,001,008
  • $30.10 ▼ 0.76%
25,347,187
  • $8.25 ▲ 1.48%
As of 8/21/2014, 04:03 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com